Companies - Galapagos

Price

 
Price
€ 111,05
Change
€ -0,45
Change %
-0,40%
Open
€ 111,50
High
€ 112,30
Low
€ 110,90
Volume
254.022

Profile

 
Profile
Galapagos is a service company for the pharmaceutical companies. It is specialized in the discovery of proteins that cause disease. The company is also active in the development of new molecules. While it focuses on arthritis, osteoporosis and osteoarthritis.
Industry
Biotechnology
Description
Companies in the biotechnology industry are performing research and development activities for the purpose of discovering new drugs and diagnostics. The turnover of these companies comes from sales of these products or the sale of licenses of drugs and diagnostic to other companies.

Key figures (2018)

 
The ratios below are calculated using the last known share price and the last known company financials.

Ratios per share

Price to Earnings
-206,729
Price to Earnings (3 years)
-199,524
Price to Earnings (5 years)
-171,707
Price to earnings growth
-
Price/cashflow
-250,161
Price/net cashflow
46,710
Price/book value
-
Price to sales
19,031

Ratios for dividend

Dividend yield
-
Pay out
-

Valuation ratios

Market value/PE
-
Market value/turnover
19,031
Enterprise value/turnover
15,542

Return ratios

Return on private equity
-
Return on total equity
-2,03%
Profit margin
-9,21%

Risk ratios

Solvability
-
Solvability
1,000
Current ratio
6,043
Debt to Equity
-

Value invest ratios

Grahams Number
€ -2,03
Grahams Value
€ -113,08
Grahams Product
-
Grahams Product (3 years)
-

2018

 

Profit and loss

Net profit (x 1 mln)
€ -29,26
Turnover (x 1 mln)
€ 317,85
Cashflow(x 1 mln)
€ -24,18
Net cashflow(x 1 mln)
€ 129,50

Balance

Private equity (x 1 mln)
-
Foreign equity (x 1 mln)
€ 1.439,50
Current assets (x 1 mln)
€ 1.328,85
Current liabilities (x 1 mln)
€ 219,90
Working capital (x 1 mln)
€ 1.108,95
Balance total (x 1 mln)
€ 1.439,50

Share

Outstanding shares (x 1 mln)
54,470
Price year-end
-
Dividend per share
-
Earnings per share
€ -0,54
Cashflow per share
€ -0,44
Net cashflow per share
€ 2,38
Book value per share
-
Stockmarket value (x 1 mln)
-

History

 
Year
2018
2017
2016
2015
2014
Net profit (x 1 mln)
€ -29,26
€ -115,70
€ 54,01
€ -118,40
€ 33,21
Turnover (x 1 mln)
€ 317,85
€ 155,92
€ 151,61
€ 60,60
€ 90,02
Price year-end
-
€ 78,98
€ 60,94
€ 56,76
€ 15,49
Year high
-
€ 89,75
€ 66,19
€ 60,55
€ 17,05
Year low
-
€ 59,13
€ 32,50
€ 14,81
€ 4,85
Outstanding shares (x 1 mln)
54,470
50,940
45,696
39,076
30,108
Price to Earnings
-
-34,773
51,559
-18,733
14,043
Earnings per share
€ -0,54
€ -2,27
€ 1,18
€ -3,03
€ 1,10
Dividends
-
-
-
-
-
Dividend yield
-
-
-
-
-
Pay out
-
-
-
-
-
Private equity (x 1 mln)
-
-
€ 758,70
€ 365,00
€ 206,14
PE per share
-
-
€ 16,60
€ 9,34
€ 6,85
Balance total (x 1 mln)
€ 1.439,50
€ 1.286,27
€ 1.083,34
€ 442,51
€ 270,47
Stockmarket value (x 1 mln)
-
€ 4.023,24
€ 2.784,71
€ 2.217,95
€ 466,37

Company analysis

 

Analysis of profit indicators

Average profit per share (7 years)
€ -0,75
Standard deviation average profit
€ 1,49 (-197,26%)
Average annual growth rate
11,26%
Compound annual growth percentage
6,62%
© 2009 Skuzet. All Rights Reserved.